News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Akhil Santhosh: Adjuvant immunotherapy trials in resected RCC
drsandeepnayak.com
Feb 5, 2025, 17:53

Akhil Santhosh: Adjuvant immunotherapy trials in resected RCC

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:

“List of adjuvant immunotherapy trials in resected RCC. Only KN 564 shwed OS, Trials with nivo, nivo-ipi and atezo were a failure. Results of RAMPART with adjuvant durvalumab/durva-tremi are pending!”

Akhil Santhosh: Adjuvant immunotherapy trials in resected RCC

Akhil Santhosh cancer OncoDaily Oncology renal cell carcinoma
Special Coverage
Science
Feb 5, 2025, 17:53
Akhil Santhosh: Adjuvant immunotherapy trials in resected RCC
Blog
Feb 5, 2025, 17:50
Miriam Mutebi: Cancer is never just a medical condition - it is a lived experience
Blog
Feb 5, 2025, 17:44
Shaban Juma: The transformative power of art to spark hope
Blog
Feb 5, 2025, 17:38
Foluke Sarimiye: A picture is worth a thousand words
Blog
Feb 5, 2025, 17:38
Walking side by side, celebrating resilience and the determination to conquer - Medicaid Cancer Foundation
Blog
Feb 5, 2025, 17:32
Unite for a future free of liver cancer - ELPA
Blog
Feb 5, 2025, 17:28
Hadieh Eslampanah: We all have a role to play in the journey towards hope and healing
Blog
Feb 5, 2025, 17:23
The EP Intergroup on Cancer and Rare Diseases held its first constitutive meeting - SIOP Europe
Blog
Feb 5, 2025, 16:59
Dickson Daniel: Together, We Are Stronger In The Fight Against Cancer
Blog
Feb 5, 2025, 16:55
Celebrating the women at Moffitt Cancer Center who are transforming cancer care through advocacy and patient-centered care
Blog
Feb 5, 2025, 16:46
Lung Cancer Policy Network - Discover the benefits of detecting lung cancer early
Blog
Feb 5, 2025, 16:08
Aditi Jain: The relationship between key Immuno-Oncology clinical trial endpoints - ORR, PFS, and OS